Diane K. Jorkasky, M.D.
Director at Alzheon.
- Framingham, MA
- Alzheon
Raised on Alzheon filings
$126.3M
of $150M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 12
- Last filing
- Feb 10, 2025
Company
Oral Alzheimer's drug targeting amyloid oligomers
- Investors
- 76
- Still open
- $23.7M
Alzheon filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Feb 10, 2025 | Equity | $126.3M/ $150M | Form D/A |
- EquityFiled Feb 10, 2025Form D/A$126.3M/ $150M
Works with
Martin Tolar, M.D., Ph.D.President and Chief Executive Officer, Form D signerForm D signerMuneer SatterDirectorAidan Power, MRCPsychChief Development OfficerChristopher Noel DunnDirectorGlenn E. PaulyChief Commercial OfficerKenneth A. MaceTreasurer and Chief Financial OfficerNeil W. FlanzraichDirectorAdem AlbayrakChief Data OfficerGino SantiniDirectorJohn Hey, Ph.D.Chief Scientific OfficerJordan HellerDirectorSusan Abushakra, M.D.Chief Medical Officer
